INVESTIGATIONAL Preclinical‑stage. Not approved by FDA.
INVESTIGATIONAL Under development. Not cleared by FDA.

Diagnostics

All news, publications, and updates from Seek Labs.

  • Seek Labs at Next Generation Dx Summit in Washington, D.C.

    Seek Labs at Next Generation Dx Summit in Washington, D.C.

    Seek Labs at Next Generation Dx Summit in Washington, D.C. August 22, 2024 The 2024 Next Generation Dx Summit, held from August 19-21 in Washington, D.C., was a gathering of forward-thinking minds in point-of-care diagnostic technologies, and Seek Labs was proud to be a key participant and sponsor. Jared Bauer, CEO, delivered a highly anticipated…

  • Seek Labs Unveils SeekIt

    Seek Labs Unveils SeekIt

    Seek Labs Unveils SeekIt™ Seek Labs’ integrated molecular diagnostic platform brings true point-of-care testing to the patient. SALT LAKE CITY, UT, November 09, 2023 (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and pharmaceuticals, today publicly announced SeekIt™, a groundbreaking molecular diagnostic testing platform. SeekIt is a complete point-of-care (POC)…

Stay connected

Follow the work as it unfolds.

Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.